Roche (RHHBY) Vows to Keep Up Drug Hunt; to Strengthen Pipeline With 72 New Molecular Entities  
9/5/2012 6:54:40 AM

Roche Holding AG (ROG.VX) Wednesday pledged to continue spending more than 8 billion Swiss francs ($8.4 billion) a year to find and develop new drugs, defying a wider trend in the pharmaceutical industry to cut costs as many of the Swiss drug maker's rivals are faced with competition from cheap generics for their best-selling products.

Roche has a stable of relatively new cancer drugs that still see enviable sales growth, and few of its blockbuster products face imminent competition.